*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
The effect of multiple intravitreal bevacizumab injection on the human corneal endothelial cells

Author: AKBAR DERAKHSHAN, MOHAMMAD SHIRVANI, ALIREZA ESLAMPOUR, MOHAMMADREZA ZARE, FARZAD NASERI , SHAHRAM BAMDAD
Abstract: Objectives: Vascular endothelial growth factor (VEGF) role in cell viability, presence of VEGF receptors on corneal endothelial cells and Bevacizumab in anterior chamber after intravitreal Bevacizumab (IVB) injection promotes the question of, is IVB injection toxic for corneal endothelial cells? Materials and Methods: 40 patients who had undergo intravitreal injection monthly for 3 times were enrolled in this study. Once before the first and again a month after the third injection, specular microscopy was performed for cases and controls and compared with each other. Results: Cell density , average cell size, standard deviation of cell size, coefficient of variation and central corneal thickness showed no significant change before and one month after the third IVB injection (p-values were 0.058, 0.077, 0.884, 0.241 and 0.202 respectively). Conclusion: IVB injection has no adverse effect on human corneal endothelial cells.
Keyword: Anti VEGF, Bevacizumab, Corneal endothelial cells, Specular microscopy, Toxicity
DOI: https://doi.org/10.31838/ijpr/2021.13.01.766
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free